Drugs / Piperacillin/tazobactam
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05943223 | Sep 2024 → Jul 2025 | appendicitis | McMaster Children's Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Piperacillin/tazobactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05943223 ↗ |
| Route | Intravenous | “piperacillin/tazobactam 100 mg/kg IV q8h” NCT05943223 ↗ |